New registry maps how targeted liver treatment is used in colorectal cancer

NCT ID NCT03086096

Completed Disease control Sponsor: Cardiovascular and Interventional Radiological Society of Europe Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry followed 152 patients with colorectal cancer that had spread mainly to the liver. Doctors used tiny beads called LifePearl Microspheres loaded with the chemotherapy drug irinotecan, delivered directly to the liver's blood supply. The goal was to see how and when this treatment is used in real-world practice, and to track safety and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LifePearl Microspheres loaded with Irinotecan
What this could lead to: If the results are positive, this could help doctors better understand when and how to use this liver-directed treatment for colorectal cancer that has spread to the liver.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove the treatment works better than other options. Results may vary widely between patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA WITH LIVER METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma colorectal carcinoma colorectal neoplasm metastatic neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CARCINOMA NEOPLASM METASTASIS

Contacts and locations

Locations

CIRSE Cardiovascular and Interventional Radiological Society of Europe

Vienna, State of Vienna, 1010, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.